Skip to main content

From Monster to Medicine: Ep. 2 – Yellow Journalism & Reefer Madness

From Medicine to Monster: Episode 2 – Yellow Journalism & Reefer Madness


Yellow Journalism and Reefer Madness


By the mid-1930s, cannabis was no longer just a plant—it was a symbol of fear, carefully crafted by those who stood to gain. Enter the era of yellow journalism, a time when sensational headlines sold papers faster than facts ever could.

William Randolph Hearst, media mogul and lumber tycoon, used his newspapers to stoke panic. Headlines screamed about “Marijuana-crazed Jazz Hounds” and “Degenerate Mexicans Threatening American Youth.” The goal? Sell papers… and protect his timber investments by demonizing hemp, a cheap alternative to paper pulp.

Hollywood joined the fray. In 1936, Reefer Madness hit the screen, depicting marijuana users spiraling into madness, crime, and sexual deviance. The film was propaganda dressed as morality play, but audiences ate it up. Teachers, parents, and politicians alike watched in horror as the “monster” of marijuana tore through society.

Meanwhile, Harry Anslinger fed the narrative with racist and sensationalist testimony to Congress. He claimed cannabis made people violent, insane, and sexually unrestrained. One Congressional hearing included tales of people committing murder under the influence of a single joint. (Spoiler: no evidence ever supported these claims.)

The combination of media hype, film hysteria, and federal propaganda cemented marijuana’s reputation as a public menace. Fear, not science, became law. By the time the Marijuana Tax Act of 1937 passed, Americans believed they were protecting their families from a monster—but the monster had been manufactured by politicians, press barons, and industrial interests.

In Episode 3: The War on Drugs & Nixon’s Legacy, we’ll see how the monster went from paper and film into federal law enforcement, becoming a national obsession that still shapes policy today.

🌿 Explore the Series 🌿

Comments

People's Choice

A Thank You Letter To President Trump for Opening the Door to Cannabis Research

  Trump's Cannabis From Schedule I to Schedule III Move Dear President Trump, I want to extend a sincere and enthusiastic thank you for your leadership in considering and moving forward with the rescheduling of marijuana from a Schedule I to a Schedule III controlled substance — a step that has already begun to reshape the national conversation around cannabis, research, and medical science. Your public remarks acknowledging that many people want this reclassification because it “leads to tremendous amounts of research that can’t be done unless you reclassify” reflect a willingness to look beyond old stigmas and recognize the potential for science and medicine to understand cannabis more fully. This shift — which would acknowledge cannabis as a substance with accepted medical use and a lower potential for abuse relative to Schedule I drugs — marks one of the most significant federal policy considerations in decades. By opening the door to research, innovation, an...

Key differences Between Schedule I and Schedule III — What Rescheduling Marijuana Could Mean

  Key differences Between Schedule I and Schedule III — What Rescheduling Marijuana Could Mean Schedule I vs Schedule III Under the U.S. Controlled Substances Act (CSA), drugs are classified into schedules based on their accepted medical use, potential for abuse, and risk of dependence. Two key schedules in this context are Schedule I and Schedule III: Schedule I : Drugs with no currently accepted medical use in the U.S., a high potential for abuse , and potentially severe psychological or physical dependence. Examples include heroin, LSD, and currently, marijuana (cannabis). Schedule III : Drugs with accepted medical use , moderate to low potential for physical and psychological dependence, and a lower abuse risk compared to Schedules I or II. Examples include ketamine, anabolic steroids, testosterone, and certain codeine combinations (like Tylenol with codeine). Rescheduling marijuana from Schedule I to Schedule III would formally recognize its medical benefits...

What Is Nerolidol?

  Because of its sedative qualities, nerolidol-rich strains are often favored for evening use or for relaxation. What Is Nerolidol? Nerolidol is a naturally occurring sesquiterpene found in many plants. It has a distinctive aroma described as woody, floral, and slightly citrusy, often reminiscent of fresh ginger, jasmine, or bark. This terpene is known for its calming, sedative qualities and is commonly used in perfumes, cosmetics, and traditional herbal medicines. Nerolidol in Cannabis In cannabis, nerolidol contributes a subtle, complex aroma that blends woodsy and floral notes. It’s less common than some other terpenes but plays an important role in the overall scent and effect profile of certain strains. Strains high in nerolidol tend to be: Woody and floral Earthy with a touch of citrus Smooth and mellow Nerolidol itself does not produce intoxication but interacts with cannabinoids like THC and CBD to shape the overall experience. Effects Commo...

The Cannabis Beverage Revolution: How THC Drinks Are Disrupting Big Alcohol (And Why Tennessee Shut Them Down)

THC-infused beverages are rapidly replacing alcohol for many consumers—triggering a coordinated backlash from the alcohol industry  that culminated in Tennessee’s 2025 hemp crackdown. The Cannabis Beverage Revolution: How THC Drinks Are Disrupting Big Alcohol (And Why Tennessee Shut Them Down) A Deep Dive Into the Fastest-Growing Segment of the Cannabis Industry—And the Billion-Dollar Threat That Triggered Tennessee's Crackdown Jump to: Market Explosion Alcohol Industry Threat Big Alcohol's Response Tennessee's Response Product Reality Health Comparison Market Reality Federal Complication Tennessee's Position The Future Conclusion When Tennessee transferred hemp regulation to the Tennessee Alcoholic Beverage Commission on January 1, 2026, most people assumed it was about public safety or protecting children. But the real story is far more revealing: it's about protecting the alcohol ind...

Free the Green: A Letter to President Donald J. Trump

  🇺🇸 Free the Green: A Letter to President Donald J. Trump An Open Plea from the American People & the Cannabis Family Legalize It President Trump, It’s time to Free the Green — to remove marijuana from the federal Schedule I classification, where it has been trapped since the Nixon era. A Law Without a Vote Few Americans realize that marijuana’s placement as a Schedule I drug — supposedly with “no medical value and a high potential for abuse” — was never voted on by Congress . It was assigned there in 1970 under the Controlled Substances Act by executive direction, intended as a temporary classification until a scientific commission could study the plant and make recommendations. That commission, known as the Shafer Commission , did complete its work — and in 1972, it recommended that marijuana should not be criminalized and should be removed from Schedule I entirely. The findings were ignored. Politics won. Science lost. And for over fifty years, that mi...